Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

INCLUDE: Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

ABSTRACT: INCLUDE: Mechanisms, Genomic Risk Stratification and Precision Intervention for Acute Myeloid Leukemia in Children with Down syndrome (ML-DS)

PROVIDER: PRJNA854740 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Murine ML-DS-like leukemias

Project description:Modelling the progression from TAM to ML-DS in children with Down syndrome utilizing a murine transplantation model

| PRJEB30376 | ENA

RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

Project description:Paired-end 150bp RNA sequencing data from ML-DS samples.

2020-12-31 | E-MTAB-7932 | biostudies-arrayexpress

RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

Project description:RNA sequencing data from Myeloid Leukaemia of Down Syndrome (ML-DS)

| PRJEB32403 | ENA

Expression data of human mesenchymal stromal cells isolated from bone marrow of ML-DS, AMKL patients and HD

Project description:Bone marrow fibrosis (BMF) is a rare complication in acute leukemia. In pediatrics, it predominantly occurs in acute megakaryoblastic leukemia (AMKL) and here especially in patients with trisomy 21, called myeloid leukemia in Down syndrome (ML-DS). Defects in mesenchymal stromal cells (MSCs) and cytokines specifically released by the myeloid blasts are the main drivers of fibrosis in the bone marrow niche (BMN). In order to determine which factors are necessary/sufficient for the BMF, we first established MSCs from pediatric patients with AMKL and ML-DS. Healthy donor (HD) control MSCs were established from children and adolescents ≤18 years of age. Steady-state analyses of the MSCs revealed that patient-derived MSCs exhibited decreased adipogenic differentiation potential, enrichment of proliferation-associated genes and upregulation of the oncofetal protein IF2B3. TGFB1 exposure in vitro promoted early profibrotic changes in all three MSC entities. To study BMF induction for longer periods of time, we created an in vivo humanized artificial BMN in immunodeficient mice. Injection of AMKL blasts as producers of TGFB1 specifically induced fibrosis grade I/II in a dose-dependent fashion, thus strongly suggesting TGFB1 excess to be sufficient for BMF. Our in vivo BMF model will be instrumental to specifically prevent the BMF and to identify potentially druggable target genes. We used microarrays to obtain a global overview of the differences between undifferentiated ML-DS- and AMKL-MSC compared to HD-MSC

2020-07-27 | GSE138861 | GEO

Picocystis sp. ML strain:ML

Project description:Picocystis sp. ML strain:ML Genome sequencing and assembly

| PRJNA490491 | ENA

INCLUDE: Human Trisome Project

Project description:INCLUDE: Human Trisome Project

| PRJNA854739 | ENA

INCLUDE: Human Trisome Project

Project description:INCLUDE: Human Trisome Project

| PRJNA854738 | ENA

Gene expression profiling of Down Syndrome (DS)-AMKL and non-DS AMKL samples

Project description:The goal of this study is to define a gene expression signature unique to DS-AMKL (acute megakaryoblastic leukemia or FAB M7 leukemia). A similar study was done previously, but using unfractionated patient leukemic samples. In this study, we sorted megakaryocytic leukemia blasts from patients and then compared their gene expression signatures to those from similarly sorted blasts from patients with non-DS AMKL. This allowed us to identify a gene expression signature more unique to DS-AMKL samples.

2010-08-01 | GSE16677 | GEO

Bacillus safensis strain:DS-1 | isolate:DS-1

Project description:Bacillus safensis strain:DS-1 | isolate:DS-1 Genome sequencing

| PRJNA1142686 | ENA

Janthinobacterium sp. DS strain:DS

Project description:Janthinobacterium sp. DS Genome sequencing and assembly

| PRJNA721696 | ENA